Molecular phenotypes are accurately defined as TopMD Maps of activated gene pathways; robust pathway biomarkers for
increased efficiency of drug development and patient treatment.
What does personalised medicine mean for you?
Technology is making it possible to tailor treatments to ever smaller groups of patients.
TopMD fights COVID-19
TopMD leads molecular phenotyping in DRAGON, the £14M EU-funded international consortium for COVID-19 advanced diagnostics.
NIH research is working hard to solve the puzzle of how genes and lifestyle connect to affect our lives and our health.